CCNE1 and diffuse large B-cell lymphoma: CCNE expression in >20% of tumor cells is an IPI-independent prognostic factor for both overall- and disease-specific survival and a predictive factor for poor response to CHOP treatment regimens in DLBCL (Tzankov et al. 2006).